title: Persistence and Discontinuation of Oral Anticoagulant: Remaining Issues Not Addressed by Phase III Clinical Trials.
authors.affiliation: Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan.
authors.forename: Kengo
authors.initials: K
authors.lastname: Ayabe
authors.affiliation: Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan.
authors.forename: Shinichi
authors.initials: S
authors.lastname: Goto
authors.affiliation: Department of Medicine (Cardiology), Tokai University School of Medicine, Isehara, Japan shinichi@is.icc.u-tokai.ac.jp.
authors.forename: Shinya
authors.initials: S
authors.lastname: Goto
mesh_terms: D000284:Administration, Oral; D000925:Anticoagulants / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy*; D006801:Humans; D020521:Stroke / Q000188:drug therapy
chemical_list: D000925:Anticoagulants
keywords: Editorials; anticoagulation; atrial fibrillation; discontinuation; stroke